Unique ID issued by UMIN | UMIN000001659 |
---|---|
Receipt number | R000002000 |
Scientific Title | Efficacy and safety of a traditional Chinese medicine yokukansan for chorea and psychosis in the Huntington's disease. |
Date of disclosure of the study information | 2009/08/01 |
Last modified on | 2011/01/07 13:09:05 |
Efficacy and safety of a traditional Chinese medicine yokukansan for chorea and psychosis in the Huntington's disease.
Traditional Chinese medicine for Huntington's disease
Efficacy and safety of a traditional Chinese medicine yokukansan for chorea and psychosis in the Huntington's disease.
Traditional Chinese medicine for Huntington's disease
Japan |
Huntington's disease
Neurology |
Others
YES
To evaluate the efficacy and safety of a traditional Chinese medicine yokukansan for the chorea and psychosis in Huntington's disease
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Unified Huntington's Disease Rating Scale (UHDRS)
Neuropsychiatric Inventry(NPI)
Cognitive function, ADL, Use of rescue drug, toralance
Interventional
Cross-over
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Medicine |
Step1. Treated with yokukansan 12 weeks
Step2. Wash out 12 weeks
Step1. 12 weeks waiting period
Step2. Treated with yokukansan 12 weeks
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Clinically diagnosed as Huntington's disease according to ICD10 with abnormal prolongation of CAG repeat in IT15 gene.
2. At least one subscore of UHDRS is more than 3.
3. Serum potassium level is within the normal limit.
4. The patients have symptoms agreed to use yokukansan with public medical insurance in Japan. It includes irritation, quick tempered, hypersensitivity and insomnia.
1. With any malignancy
2. With severe heart disease, liver disease, blood disease, respiratory disease and any other severe diseases influenced on the patients states
3. With any neurodegenerating diseases other than Huntington's disease
4. Alcohol abuse, drug abuse, metabolic toxicity, chronic inflammatory diseases
5. Who can not take the herbal medicine.
6. Who are perscribed any antipsychotics newly in the observation period.
7. Others who are judged as inadequate by attending doctors.
20
1st name | |
Middle name | |
Last name | Atsushi Takeda |
Tohoku University Graduate school of medicine
Department of Neurology
1-1 Seiryo-cho, Aoba Ward, Sendai City Miyagi Japan
022-717-7189
1st name | |
Middle name | |
Last name | Koh Iwasaki |
Tohoku University Graduate school of medicine
Center for Asian Traditional Medicine
1-1 Seiryo-cho, Aoba Ward, Sendai City Miyagi Japan
022-717-7185
QFG03604@nifty.com
Dept. Nerol and Center for traditional Asian medicine, Tohoku University Graduate school of medicine
Ministry of Education, Culture, Sports, Science and Technology, Grant-in-aid scientific research (now in apply).
Japan
Ntional hospital organization Yonezawa hospital
Nishitaga national hospital
Osaka prefectural hospital organization, medical center
National center of neurology and psychiatry
NO
2009 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2009 | Year | 01 | Month | 24 | Day |
2009 | Year | 03 | Month | 01 | Day |
2010 | Year | 05 | Month | 01 | Day |
2010 | Year | 08 | Month | 01 | Day |
2010 | Year | 10 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2009 | Year | 01 | Month | 26 | Day |
2011 | Year | 01 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002000
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |